Health Data Integration Life Sciences Pharmaceuticals 
HIT Consultant
MAY 15, 2023
Flatiron’s new Integrated RWE Solutions will include data and end-to-end services to provide a more flexible and fit-for-purpose approach to address growing oncology RWE needs—from early development through late-stage commercialization.
Health Populi
APRIL 6, 2022
He had me at the statement, “I believe health data is medicine.”. We met up last week at the DIA Europe 2022 meeting (Drug Information Association) in the cool SQUARE Conference Center in Brussels, Belgium (my current home base for work and life).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
JANUARY 14, 2022
. – Existing Verana Health investors GV (formerly Google Ventures), Casdin Capital , and Brook Byers also joined the round, as well as notable new investors, including the Merck Global Health Innovation Fund , THVC , and Breyer Capital. Empowering Physicians & Life Science Companies. Expansion Plans.
Healthcare It News
JUNE 29, 2022
GluCare.Health – named amongst the 50 most-funded startups in the region by Forbes Middle East at $20 million – and the Danish multinational pharmaceutical company will kick off their partnership with a 150-patient weight management pilot programme in the United Arab Emirates (UAE). THE LARGER CONTEXT.
HIT Consultant
SEPTEMBER 1, 2023
The use of automated technology systems like digital workflows, orchestration and storing of data digitally is helping to shape their application, enabling far greater personalization of treatment for patients and greater efficiency and speed of clinical trials.
Health Populi
AUGUST 22, 2022
And that data will be generated from many sources, frequently siloed and decentralized which can prevent aggregation, mash-up, and analysis. In particular, the volume of health data from wearables, implantables, and other decentralized technologies is growing by 48% annually, according to a recent report from the Swiss Re Institute.
HIT Consultant
JANUARY 24, 2022
These and other questions are compelling us, as AI practitioners, to think differently in terms of how we can best advance clinical research and precision medicine using responsible AI that benefits patients, providers, payers, pharmaceutical companies and medical care professionals while avoiding unintended consequences, including bias.
Expert insights. Personalized for you.
98 
Let's personalize your content